RxDoctor Payments Data

Patricia Hall, PA

Physician Assistant · Edmond, OKNPI 1922284488

Payments from drug & device makers

$5,741in general payments, 2019–2025

Across 334 payments — averaging $17.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$577
  • AstraZeneca$438
  • Astellas Pharma US Inc$388
  • Lilly USA, LLC$285
  • Bayer$283
  • plus $3K from 48 others

What the payments were for

  • Food & beverage$5,64198%
  • Education$1002%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,741 in reported general payments places this provider in the 90th percentile of 1,491 physician assistant providers in Oklahoma.

See all physician assistant providers in Oklahoma

Medicare billing

Part B allowed, 2024
$70,214
Medicare patients
453
Services billed
1,388

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide13$17,546
MyrbetriqMirabegron14$7,455
ProgesteroneProgesterone, Micronized187$7,190
Estradiol (Twice Weekly)Estradiol34$3,559
Estradiol25$2,102
DottiEstradiol22$1,785
Liothyronine Sodium65$1,762
LyllanaEstradiol12$1,545
Levothyroxine Sodium103$1,012
SynthroidLevothyroxine Sodium12$564
Spironolactone24$459
Atorvastatin Calcium35$255
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst17$245
Doxycycline Hyclate22$160
Fluticasone Propionate14$148

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$285$17,54613 claims
Astellas Pharma US IncMyrbetriq$388$7,45514 claims
AbbVieSynthroid$1,183$56412 claims
PfizerPaxlovid$253$011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,491 physician assistant providers in Oklahoma.

Other physician assistant in Edmond

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →